Page last updated: 2024-08-23

paclitaxel and Epiphora

paclitaxel has been researched along with Epiphora in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (57.14)29.6817
2010's1 (14.29)24.3611
2020's2 (28.57)2.80

Authors

AuthorsStudies
Etminan, M; Maberley, D; Mikelberg, F; Sodhi, M; Yeung, SN1
Contorno, T; McGwin, G; Owsley, C; Vicinanzo, MG1
Bakhski, S; Gupta, B; Kashyap, S; Meel, R; Sharma, S; Surve, A1
Estephan, FF; Jones, DV; Lin, JT; Spell, DW1
Ahmadi, MA; Booser, D; Esmaeli, B; Valero, V1
Esmaeli, B; Hortobagyi, GN1
Ahmadi, MA; Arbuckle, R; Booser, D; Delpassand, E; Esmaeli, B; Esteva, F; Hortobagyi, G; Ibrahim, N; Valero, V1

Other Studies

7 other study(ies) available for paclitaxel and Epiphora

ArticleYear
Risk of Ocular Adverse Events With Taxane-Based Chemotherapy.
    JAMA ophthalmology, 2022, 09-01, Volume: 140, Issue:9

    Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Bridged-Ring Compounds; Child; Docetaxel; Female; Humans; Lacrimal Apparatus Diseases; Macular Edema; Middle Aged; Optic Nerve Diseases; Paclitaxel; Retrospective Studies; Tamoxifen; Taxoids

2022
The Association Between Taxane Use and Lacrimal Disorders.
    Current eye research, 2023, Volume: 48, Issue:9

    Topics: Docetaxel; Humans; Lacrimal Apparatus Diseases; Paclitaxel; Taxoids; United States

2023
A Rare Case of Pediatric Lacrimal Sac: Squamous Cell Carcinoma.
    Journal of pediatric ophthalmology and strabismus, 2019, Feb-08, Volume: 56

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Fine-Needle; Carboplatin; Carcinoma, Squamous Cell; Child; Eye Neoplasms; Humans; Lacrimal Apparatus Diseases; Lymphadenopathy; Male; Neoadjuvant Therapy; Paclitaxel; Tomography, X-Ray Computed

2019
Epiphora induced by intermittent docetaxel (taxotere) in patients with non-small cell lung cancer.
    Cancer investigation, 2003, Volume: 21, Issue:4

    Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Docetaxel; Humans; Lacrimal Apparatus Diseases; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Taxoids

2003
Canalicular stenosis secondary to docetaxel (taxotere): a newly recognized side effect.
    Ophthalmology, 2001, Volume: 108, Issue:5

    Topics: Adult; Antineoplastic Agents, Phytogenic; Docetaxel; Female; Fibrosis; Humans; Lacrimal Apparatus; Lacrimal Apparatus Diseases; Lacrimal Duct Obstruction; Middle Aged; Paclitaxel; Taxoids; Tears

2001
Canalicular stenosis as the underlying mechanism for epiphora in patients receiving weekly docetaxel.
    The oncologist, 2001, Volume: 6, Issue:6

    Topics: Antineoplastic Agents, Phytogenic; Humans; Lacrimal Apparatus Diseases; Lacrimal Duct Obstruction; Paclitaxel

2001
Canalicular stenosis secondary to weekly docetaxel: a potentially preventable side effect.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:2

    Topics: Adult; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Docetaxel; Female; Humans; Lacrimal Apparatus Diseases; Lacrimal Duct Obstruction; Middle Aged; Paclitaxel; Taxoids

2002